Effect of Increased IL-1β on Expression of HK in Alzheimer’s Disease
Open Access
- 28 January 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (3) , 1306
Abstract
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by decreased glucose metabolism and increased neuroinflammation. Hexokinase (HK) is the key enzyme of glucose metabolism and is associated with mitochondria to exert its function. Recent studies have demonstrated that the dissociation of HK from mitochondria is enough to activate the NOD-like receptor protein 3 (NLRP3) inflammasome and leads to the release of interleukin-1β (IL-1β). However, the effect of increased IL-1β on the expression of HK is still unclear in AD. In this paper, we used positron emission tomography (PET), Western blotting and immunofluorescence to study the glucose metabolism, and the expression and distribution of HK in AD. Furthermore, we used lipopolysaccharide (LPS), nigericin (Nig), CY-09 and lonidamine (LND) to treat N2a and N2a-sw cells to investigate the link between IL-1β and HK in AD. The results show decreased expression of HK and the dissociation of HK from mitochondria in AD. Furthermore, a reduction of the expression of IL-1β could increase the expression of HK in AD. These results suggest that inhibiting inflammation may help to restore glucose metabolism in AD.Keywords
Funding Information
- National Key Research and Development Program of China (2016YFF0101500)
- National Natural Science Foundation of China (61927801, 61671215, 21877081)
This publication has 27 references indexed in Scilit:
- RETRACTED: mTORC1-Induced HK1-Dependent Glycolysis Regulates NLRP3 Inflammasome ActivationCell Reports, 2015
- Direct neuronal glucose uptake heralds activity-dependent increases in cerebral metabolismNature Communications, 2015
- Uptake and metabolism of fructose by rat neocortical cells in vivo and by isolated nerve terminals in vitroJournal of Neurochemistry, 2015
- Age-dependent metabolic dysregulation in cancer and Alzheimer’s diseaseBiogerontology, 2014
- Hexokinase 1 blocks apoptotic signals at the mitochondriaCellular Signalling, 2013
- NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 miceNature, 2012
- Mitochondrial detachment of hexokinase 1 in mood and psychotic disorders: Implications for brain energy metabolism and neurotrophic signalingJournal of Psychiatric Research, 2012
- Amyloid-β Triggers the Release of Neuronal Hexokinase 1 from MitochondriaPLOS ONE, 2010
- Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and AktOncogene, 2006
- Mitochondrial Bound Hexokinase Activity as a Preventive Antioxidant DefenseJournal of Biological Chemistry, 2004